NCT01324830View on ClinicalTrials.gov

Monotherapy Dose Finding With BI 847325 in Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

April 15, 2011

Primary Completion Date

June 6, 2013

Study Completion Date

October 10, 2013

Conditions
Neoplasms
Interventions
DRUG

day 1 to day 5

low to high dose

DRUG

day 1 to day 14

low to high dose

Trial Locations (2)

Unknown

1287.1.3201 Boehringer Ingelheim Investigational Site, Brussels

1287.1.3202 Boehringer Ingelheim Investigational Site, Leuven

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY